Acorah Software Products - Accounts Production 16.6.920 false true 31 December 2023 1 January 2023 false true No description of principal activity 1 January 2024 31 December 2024 31 December 2024 12368131 Mr Azhar Aziz iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 12368131 2023-12-31 12368131 2024-12-31 12368131 2024-01-01 2024-12-31 12368131 frs-bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 12368131 frs-bus:FilletedAccounts 2024-01-01 2024-12-31 12368131 frs-bus:Micro-entities 2024-01-01 2024-12-31 12368131 frs-bus:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 12368131 frs-bus:Director1 2024-01-01 2024-12-31 12368131 2022-12-31 12368131 2023-12-31 12368131 2023-01-01 2023-12-31
Registered number: 12368131
Livepharma Limited
Unaudited Financial Statements
For The Year Ended 31 December 2024
Balance Sheet
Registered number: 12368131
2024 2023
£ £
Fixed assets 10,035 10,035
Current assets 30 30
NET CURRENT ASSETS 30 30
TOTAL ASSETS LESS CURRENT LIABILITIES 10,065 10,065
Accruals and deferred income (1,200 ) (1,200 )
NET ASSETS 8,865 8,865
CAPITAL AND RESERVES 8,865 8,865

Notes

1. General Information
Livepharma Limited is a private company, limited by shares, incorporated in England & Wales, registered number 12368131 . The registered office is Unit 3, 52 George Street, Rochdale, OL16 2DA.
2. Average Number of Employees
Average number of employees, including directors, during the year was: NIL (2023: NIL)
- -
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Mr Azhar Aziz
Director
29/10/2025